Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 285

1.

Baseline factors affecting closure of venous leg ulcers.

Marston WA, Ennis WJ, Lantis JC 2nd, Kirsner RS, Galiano RD, Vanscheidt W, Eming SA, Malka M, Cargill DI, Dickerson JE Jr, Slade HB; HP802-247 Study Group.

J Vasc Surg Venous Lymphat Disord. 2017 Nov;5(6):829-835.e1. doi: 10.1016/j.jvsv.2017.06.017.

PMID:
29037354
2.

Use of Implementation Science for a Sustained Reduction of Central-Line-Associated Bloodstream Infections in a High-Volume, Regional Burn Unit.

Sood G, Caffrey J, Krout K, Khouri-Stevens Z, Gerold K, Riedel S, McIntyre J, Maragakis LL, Blanding R, Zenilman J, Bennett R, Pronovost P.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1306-1311. doi: 10.1017/ice.2017.191. Epub 2017 Sep 13.

PMID:
28899444
3.

Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Milbrandt M, Winter AC, Nevin RL, Pakpahan R, Bradwin G, De Marzo AM, Elliott DJ, Gaydos CA, Isaacs WB, Nelson WG, Rifai N, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2017 May;77(13):1325-1334. doi: 10.1002/pros.23392. Epub 2017 Jul 12.

PMID:
28703328
4.

Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study.

Nayak SU, Griffiss JM, Blumer J, O'Riordan MA, Gray W, McKenzie R, Jurao RA, An AT, Le M, Bell SJ, Ochsner UA, Jarvis TC, Janjic N, Zenilman JM.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02760-16. doi: 10.1128/AAC.02760-16. Print 2017 Aug.

PMID:
28584140
5.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.

Vickers RJ, Tillotson GS, Nathan R, Hazan S, Pullman J, Lucasti C, Deck K, Yacyshyn B, Maliakkal B, Pesant Y, Tejura B, Roblin D, Gerding DN, Wilcox MH; CoDIFy study group.

Lancet Infect Dis. 2017 Jul;17(7):735-744. doi: 10.1016/S1473-3099(17)30235-9. Epub 2017 Apr 28.

6.

High Burden of Antimicrobial Resistance and Mortality Among Adults and Children With Community-Onset Bacterial Infections in India.

Mave V, Chandanwale A, Kagal A, Khadse S, Kadam D, Bharadwaj R, Dohe V, Robinson ML, Kinikar A, Joshi S, Raichur P, McIntire K, Kanade S, Sachs J, Valvi C, Balasubramanian U, Kulkarni V, Milstone AM, Marbaniang I, Zenilman J, Gupta A.

J Infect Dis. 2017 Apr 15;215(8):1312-1320. doi: 10.1093/infdis/jix114.

PMID:
28329303
7.

Pseudo-outbreak of Penicillium in an outpatient obstetrics and gynecology clinic.

Sood G, Huber K, Dam L, Riedel S, Grubb L, Zenilman J, Perl TM, Argani C.

Am J Infect Control. 2017 May 1;45(5):557-558. doi: 10.1016/j.ajic.2017.01.001. Epub 2017 Feb 8.

PMID:
28189414
8.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.

N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.

9.
10.

Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers.

Kirsner RS, Vanscheidt W, Keast DH, Lantis JC 2nd, Dove CR, Cazzell SM, Vartivarian M, Augustin M, Marston WA, McCoy Bs ND, Cargill PhD DI, Lee Mshs TD, Dickerson JE Jr, Slade Md HB; HP802-247 Study Group.

Wound Repair Regen. 2016 Sep;24(5):894-903. doi: 10.1111/wrr.12467. Epub 2016 Sep 26.

PMID:
27495869
11.

Clinical interventions for venous leg ulcers: Proposals to improve the quality of clinical leg ulcer research.

Lazarus GS, Kirsner RS, Zenilman J, Valle MF, Margolis DJ, Cullum N, Driver VR, Gould L, Lindsay E, Tunis S, Marston W, Bass E, Ennis W, Davidson J, Bowden J.

Wound Repair Regen. 2016 Sep;24(5):767-774. doi: 10.1111/wrr.12466. Epub 2016 Aug 24.

PMID:
27487792
12.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, Hook EW 3rd, Kubin G, Riedel S, Zenilman J, Pettus K, Sanders T, Sharpe S, Torrone E.

MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.

PMID:
27414503
13.

Predicting Unprotected Sex and Unplanned Pregnancy among Urban African-American Adolescent Girls Using the Theory of Gender and Power.

Rosenbaum JE, Zenilman J, Rose E, Wingood G, DiClemente R.

J Urban Health. 2016 Jun;93(3):493-510. doi: 10.1007/s11524-016-0047-8.

14.

Semen says: assessing the accuracy of adolescents' self-reported sexual abstinence using a semen Y-chromosome biomarker.

Rosenbaum JE, Zenilman JM, Rose E, Wingood GM, DiClemente RJ.

Sex Transm Infect. 2017 Mar;93(2):145-147. doi: 10.1136/sextrans-2016-052605. Epub 2016 May 4.

PMID:
27147615
15.

Medical and surgical treatment of chronic venous ulcers.

Cooper MA, Qazi U, Bass E, Zenilman J, Lazarus G, Valle MF, Malas MB.

Semin Vasc Surg. 2015 Sep-Dec;28(3-4):160-4. doi: 10.1053/j.semvascsurg.2015.12.003. Epub 2015 Dec 22. Review.

PMID:
27113282
16.

Approaches to Modifying the Behavior of Clinicians Who Are Noncompliant With Antimicrobial Stewardship Program Guidelines.

Goldstein EJ, Goff DA, Reeve W, Naumovski S, Epson E, Zenilman J, Kaye KS, File TM Jr.

Clin Infect Dis. 2016 Aug 15;63(4):532-8. doi: 10.1093/cid/ciw247. Epub 2016 Apr 20.

PMID:
27098167
17.

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.

Sutcliffe S, Nevin RL, Pakpahan R, Elliott DJ, Langston ME, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Walsh PC, Zenilman JM, Cersovsky SB, Platz EA.

Int J Cancer. 2016 May 1;138(9):2221-30. doi: 10.1002/ijc.29966. Epub 2016 Jan 21.

18.

Sexually Transmitted Diseases and Travel: From Boudoir to Bordello.

Avery AK, Zenilman JM.

Microbiol Spectr. 2015 Oct;3(5). doi: 10.1128/microbiolspec.IOL5-0011-2015. Review.

PMID:
26542045
19.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Kirkcaldy RD, Hook EW 3rd, Soge OO, del Rio C, Kubin G, Zenilman JM, Papp JR.

JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347. No abstract available.

20.

Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.

Zenilman JM, Fuchs EJ, Hendrix CW, Radebaugh C, Jurao R, Nayak SU, Hamilton RG, McLeod Griffiss J.

Antiviral Res. 2015 Nov;123:114-9. doi: 10.1016/j.antiviral.2015.09.008. Epub 2015 Sep 25.

Supplemental Content

Loading ...
Support Center